Accelerated atherosclerosis, arterial thromboembolism, and preventive strategies in systemic lupus erythematosus

被引:42
作者
Mok, CC [1 ]
机构
[1] Tuen Mun Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China
关键词
D O I
10.1080/03009740600601526
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
With improved disease survival, arterial thromboembolism has become an important cause of morbidity in patients with systemic lupus erythematosus ( SLE). A number of conventional and non-conventional risk factors are associated with accelerated atherosclerosis. Regular surveillance and control of traditional risk factors is mandatory, and so is the appropriate use of the statins, anti-malarial agents, anti-platelet agents, and anticoagulation for primary and secondary prevention of arterial thromboembolism in SLE patients. Judicious use of corticosteroids, calcineurin inhibitors, hormonal replacement therapy, and the cyclooxygenase 2 inhibitors is equally important.
引用
收藏
页码:85 / 95
页数:11
相关论文
共 105 条
[1]  
Adler Y, 2005, INT J CARDIOL, V101, P371, DOI 10.1016/j.ijcard.2004.03.044
[2]   Premature coronary-artery atherosclerosis in systemic lupus erythematosus [J].
Asanuma, Y ;
Oeser, A ;
Shintani, AK ;
Turner, E ;
Olsen, N ;
Fazio, S ;
Linton, MF ;
Raggi, P ;
Stein, CM .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (25) :2407-2415
[3]   CD4+ regulatory T cells:: Mechanisms of induction and effector function [J].
Bacchetta, R ;
Gregori, S ;
Roncarolo, MG .
AUTOIMMUNITY REVIEWS, 2005, 4 (08) :491-496
[4]   Raloxifene and cardiovascular events in osteoporotic postmenopausal women - Four-year results from the MORE (Multiple Outcomes of Raloxifene Evaluation) randomized trial [J].
Barrett-Connor, E ;
Grady, D ;
Sashegyi, A ;
Anderson, PW ;
Cox, DA ;
Hoszowski, K ;
Rautaharju, P ;
Harper, KD .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (07) :847-857
[5]   Prospective analysis of mannose-binding lectin genotypes and coronary artery disease in American Indians - The Strong Heart Study [J].
Best, LG ;
Davidson, M ;
North, KE ;
MacCluer, JW ;
Zhang, Y ;
Lee, ET ;
Howard, BV ;
DeCroo, S ;
Ferrell, RE .
CIRCULATION, 2004, 109 (04) :471-475
[6]  
Björnådal L, 2004, J RHEUMATOL, V31, P713
[7]  
Borba EF, 2001, J RHEUMATOL, V28, P780
[8]   Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial [J].
Bresalier, RS ;
Sandler, RS ;
Quan, H ;
Bolognese, JA ;
Oxenius, B ;
Horgan, K ;
Lines, C ;
Riddell, R ;
Morton, D ;
Lanas, A ;
Konstam, MA ;
Baron, JA .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (11) :1092-1102
[9]   Neuropsychiatric syndromes in lupus -: Prevalence using standarized definitions [J].
Brey, RL ;
Holliday, SI ;
Saklad, AR ;
Navarrete, MG ;
Hermosillo-Romo, D ;
Stallworth, CL ;
Valdez, CR ;
Escalante, A ;
del Rincón, I ;
Gronseth, G ;
Rhine, CB ;
Padilla, P ;
McGlasson, D .
NEUROLOGY, 2002, 58 (08) :1214-1220
[10]  
Bruce IN, 1999, J RHEUMATOL, V26, P2137